Roche's Tecentriq receives positive opinion from EU medicines agency

1 hours ago
ZURICH (Reuters) - A European Medicines Agency (EMA) panel said on Friday it has recommended Roche's immunotherapy Tecentriq as a treatment for advanced bladder and lung cancer, setting the stage for European Commission approval this year.

More Health News

21 Jul 2017

U.S. CDC says salmonella outbreak linked to papayas sickens 47

(Reuters) - An outbreak of salmonella food poisoning linked to a type of papaya has sickened 47 people from 12 states, including one person in New York City who died and 12 who were hospitalized, U.S. health officials said on Friday.

21 Jul 2017

Bayer says asbestos-related tumor treatment misses key goal

FRANKFURT (Reuters) - Germany's Bayer said on Friday a cancer treatment for patients with a type of tumor often caused by asbestos had failed to meet its main goal in a clinical trial.

21 Jul 2017

Europe backs nuclear medicine for cancer that killed Steve Jobs

LONDON (Reuters) - A nuclear medicine targeting the type of cancer that killed Steve Jobs won a green light from EU regulators on Friday, boosting prospects for its developer Advanced Accelerator Applications.

21 Jul 2017

LGBT conference in China's 'gay capital' scuppered

BEIJING (Reuters) - Organizers of an LGBT conference in China's "gay capital" had to scrap the event this week, the second time in as many months a public seminar aimed at expanding awareness of lesbian, gay bisexual and transgender (LGBT) issues has run into snags.

Top News Videos